Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
PHASE1
This phase I trial finds the best dose of PVEK when given together with flu...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive
PHASE3
The primary objective of the study is to determine whether quizartinib mono...
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
PHASE1
This phase I trial studies the best dose of total body irradiation when giv...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium